These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15292653)

  • 1. Radioligand binding and functional characterization of recombinant human NmU1 and NmU2 receptors stably expressed in clonal human embryonic kidney-293 cells.
    Aiyar N; Disa J; Foley JJ; Buckley PT; Wixted WE; Pullen M; Shabon U; Dul E; Szekeres PG; Elshourbagy NA; Sarau HM; Appelbaum E; Bolaky J
    Pharmacology; 2004 Sep; 72(1):33-41. PubMed ID: 15292653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.
    Brighton PJ; Szekeres PG; Wise A; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.
    Gartlon J; Szekeres P; Pullen M; Sarau HM; Aiyar N; Shabon U; Michalovich D; Steplewski K; Ellis C; Elshourbagy N; Duxon M; Ashmeade TE; Harrison DC; Murdock P; Wilson S; Ennaceur A; Atkins A; Heidbreder C; Hagan JJ; Hunter AJ; Jones DN
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):1-14. PubMed ID: 15205870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU1 receptor activation.
    Dass NB; Bassil AK; North-Laidler VJ; Morrow R; Aziz E; Tuladhar BR; Sanger GJ
    Br J Pharmacol; 2007 Feb; 150(4):502-8. PubMed ID: 17211455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous expression and comparative characterization of the human neuromedin U subtype II receptor using the methylotrophic yeast Pichia pastoris and mammalian cells.
    Shukla AK; Haase W; Reinhart C; Michel H
    Int J Biochem Cell Biol; 2007; 39(5):931-42. PubMed ID: 17445746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissue.
    Brighton PJ; Wise A; Dass NB; Willars GB
    J Pharmacol Exp Ther; 2008 Apr; 325(1):154-64. PubMed ID: 18180374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay.
    Li X; Shen F; Zhang Y; Zhu J; Huang L; Shi Q
    Eur J Pharm Biopharm; 2007 Aug; 67(1):284-92. PubMed ID: 17337170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system.
    Mitchell JD; Maguire JJ; Kuc RE; Davenport AP
    Cardiovasc Res; 2009 Feb; 81(2):353-61. PubMed ID: 18987052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of receptors for neuromedin U and its role in feeding.
    Howard AD; Wang R; Pong SS; Mellin TN; Strack A; Guan XM; Zeng Z; Williams DL; Feighner SD; Nunes CN; Murphy B; Stair JN; Yu H; Jiang Q; Clements MK; Tan CP; McKee KK; Hreniuk DL; McDonald TP; Lynch KR; Evans JF; Austin CP; Caskey CT; Van der Ploeg LH; Liu Q
    Nature; 2000 Jul; 406(6791):70-4. PubMed ID: 10894543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterisation of two cDNAs encoding the neuromedin U receptor from goldfish brain.
    Maruyama K; Kaiya H; Miyazato M; Konno N; Wakasugi T; Uchiyama M; Shioda S; Murakami N; Matsuda K
    J Neuroendocrinol; 2011 Mar; 23(3):282-91. PubMed ID: 21182546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1.
    Johnson EN; Appelbaum ER; Carpenter DC; Cox RF; Disa J; Foley JJ; Ghosh SK; Naselsky DP; Pullen MA; Sarau HM; Scheff SR; Steplewski KM; Zaks-Zilberman M; Aiyar N
    J Immunol; 2004 Dec; 173(12):7230-8. PubMed ID: 15585845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.
    Prendergast CE; Morton MF; Figueroa KW; Wu X; Shankley NP
    Br J Pharmacol; 2006 Apr; 147(8):886-96. PubMed ID: 16474416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
    Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
    Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a novel vasospastic transmitter system, neuromedin U, in the equine digital circulation.
    Mitchell JD; Kuc RE; Maguire JJ; Davenport AP
    Vet J; 2010 Oct; 186(1):106-9. PubMed ID: 19683464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
    Witt-Enderby PA; Dubocovich ML
    Mol Pharmacol; 1996 Jul; 50(1):166-74. PubMed ID: 8700109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromedin U and its receptors: structure, function, and physiological roles.
    Brighton PJ; Szekeres PG; Willars GB
    Pharmacol Rev; 2004 Jun; 56(2):231-48. PubMed ID: 15169928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, expression, and functional analysis of human dopamine D1 receptors.
    Sun WC; Jin L; Cao Y; Wang LZ; Meng F; Zhu XZ
    Acta Pharmacol Sin; 2005 Jan; 26(1):27-32. PubMed ID: 15659110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice.
    Wang F; Zhang Y; Jiang X; Zhang Y; Zhang L; Gong S; Liu C; Zhou L; Tao J
    Cell Calcium; 2011 Jan; 49(1):12-22. PubMed ID: 21106238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-Specific Signaling Profiles and Resensitization Mechanisms of the Neuromedin U2 Receptor.
    Alhosaini K; Bahattab O; Qassam H; Challiss RAJ; Willars GB
    Mol Pharmacol; 2018 Jul; 94(1):674-688. PubMed ID: 29724789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.